Effectiveness and safety of radioiodine therapy for Graves' disease
https://doi.org/10.14341/probl200753524-27
Abstract
In 2005, in the MD PU City Hospital No. 13 of Nizhny Novgorod, a radiological department was created on the basis of a radioisotope laboratory for treating patients with Graves' disease with a radioiodine, which treats patients in the Nizhny Novgorod region and other regions of Russia.
OBJECTIVE: to determine the effectiveness of radioiodine therapy in Graves disease and the dependence of the outcome on the applied 131I activities and thyrostatic therapy.
About the Authors
G. V. ShestakovaNizhny Novgorod State Medical Academy; Nizhny Novgorod City Hospital No. 13
Russian Federation
L. G. Strongin
Nizhny Novgorod State Medical Academy
Russian Federation
M. L. Budkina
Nizhny Novgorod State Medical Academy
Russian Federation
N. A. Sidorova
Nizhny Novgorod City Hospital No. 13
Russian Federation
N. Z. Podupeiko
Nizhny Novgorod City Hospital No. 13
Russian Federation
A. V. Shestakova
Nizhny Novgorod State Medical Academy
Russian Federation
References
1. Герасимов Г. А., Мельниченко Г. А., Петунина Н. А., Федак И. Р. // Пробл. эндокринол. - 1997. - № 1. - С. 28-31.
2. Фадеев В. В., Дроздовский Б. Я., Гусева Т. Н. и др. // Пробл. эндокринол. - 2005. - Т. 51, № 1. - С. 3-10.
3. Angusti Т. et al. // J. Nucl. Med. - 2000. - Vol.41. -P. 1006-1009.
4. Bonnema S. J., Bennedbaek F. N.. Gram J. et al. // Eur. J. Endocrinol. - 2003. - Vol. 149, N 6. - P. 485-492.
5. Bonnema S. J., Bennedbaek F. N., Veje A. et al. // J. Clin. Endocrinol. Metab. - 2004. - Vol. 89, N 9. - P. 4439-4444.
6. Bonnema S. J., Bennedbaek F. N.. Veje A. et al. // J. Clin. Endocrinol. Metab. - 2006.
7. Burch H. B. et al. // Ann. Intern. Med. - 1994. - Vol. 121. - P. 553-559.
8. Carlier Т., Salaun P. Y., Cavarec M. B. et al. // Nucl. Med. Commun. - 2006. - Vol. 27, N 7. - P. 559-566.
9. Cunnien A. J., Hay I. D., Gorman С A. et al. // J. Nucl. Med. - 1982. - Vol. 23, N 11. - P. 978-983.
10. Eschmann S. M., Thelen M. H., Dittmann H. et al. // Exp. Clin. Endocrinol. Diabet. - 2006. - Vol. 114. N 5. - P. 222-226.
11. Grosso M., Traino A., Boni G. et al. // Cancer Biother. Radiopharm. - 2005. - Vol. 20, N 2. - P. 218-223.
12. Hamburger J. I. // J. Clin. Endocrinol. Metab. - 1985. - Vol. 60. - P. 1019-1024.
13. Нао S. Т., Reasner С. A., Becker R, А. // Endocr. Pract. - 2001. - Vol. 7, N 6. - P. 484-485.
14. Henneman G., Krenning E. P., Sankaranarayanan K. // Lancet. -1986. - Vol. 1. - P. 1369-1372.
15. Holm L. E, Dahlqvlst I., Israelson A. et al. // N. Engl. J. Med. - 1980. - Vol. 303. - P. 188-192.
16. Kendall-Taylor P., Keir M. J., Ross W. M. // Br. Med. J. -1984. - Vol. 289, N 6441. - P. 361-363.
17. Metso S., Jaatinen P., Huhtala H. et al. // Clin. Endocrinol. (Oxford). - 2004. - Vol. 61, N 5. - P. 641-648.
18. Nordyke R. A., Gilbert F. I., Jr. // J. Nucl. Med. - 1991. -Vol. 32.-P. 411-416.
19. Saenger E. L., Thoma G. E., Thomkins E. A. // J. A. M. A. - 1968. - Vol. 205. - P. 147-152.
20. Santos R. В., Romaldlnl J. H., Ward L. S. // Thyroid. - 2004. - Vol. 14, N 7. - P. 525-530.
21. Shapiro B. // J. Nucl. Med. - 1993. - Vol. 34. - P. 1638-1641.
22. Tajiri J. // Kaku Igaku. - 2005. - Vol. 42, N 2. - P. 115- 122.
Review
For citations:
Shestakova G.V., Strongin L.G., Budkina M.L., Sidorova N.A., Podupeiko N.Z., Shestakova A.V. Effectiveness and safety of radioiodine therapy for Graves' disease. Problems of Endocrinology. 2007;53(5):24-27. (In Russ.) https://doi.org/10.14341/probl200753524-27
Views:
2550
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
